A review of more than 20 studies by researchers at Arizona State University and the Translational Genomics Research Institute (TGen),
Continue reading »
Home »
Galvumet
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GALVUMET® Vildagliptin/Metformin hydrochloride Consumer Medicine Information What
Continue reading »
APO-Metformin XR
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-METFORMIN XR Contains the active ingredient metformin
Continue reading »
Circadian Rhythm and Weight Loss
Skip to: What is the Circadian Rhythm? Circadian Rhythm and Weight Loss Research Implications Circadian Rhythm and Diabetes Circadian Rhythm
Continue reading »
Disruption of glucose transport to rods and cones shown to cause vision loss in retinitis pigmentosa
Retinitis pigmentosa (RP) is a common hereditary eye disorder that leads to the gradual deterioration of rod cells causing reduced
Continue reading »
Closed-loop ‘artificial pancreas’ insulin delivery system offers better glucose control, reduced risk of hypoglycaemia
New research presented at this year’s annual meeting of the European Association for the Study of Diabetes (EASD) in Berlin,
Continue reading »
Basal insulin analogues similar for glucose lowering
(HealthDay)—Basal insulin analogues for type 2 diabetes mellitus (T2DM) do not substantially differ in their glucose-lowering effect, according to a
Continue reading »
FDA Approves Continuous Glucose Monitoring System
THURSDAY, June 28, 2018 — The Eversense Continuous Glucose Monitoring (CGM) system, which has a fully implantable sensor to detect
Continue reading »